Health · 1 sources covering this

STAT+: Pharmalittle: We’re reading about drug launch prices, an AstraZeneca AI deal, and more

The median net price for newly launched medicines, when adjusted for inflation and manufacturer discounts, rose by 35% from 2022 to 2025.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·3h ago
STAT+: Pharmalittle: We’re reading about drug launch prices, an AstraZeneca AI deal, and more
The median net price for newly launched medicines, when adjusted for inflation and manufacturer discounts, rose by 35% from 2022 to 2025.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/142ccd48ddc17c528b3b1c6f0947eb192bf0a136"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about drug launch prices, an AstraZeneca AI deal, and more"></iframe>

STAT+: Pharmalittle: We’re reading about drug launch prices, an AstraZeneca AI deal, and more

How 1 sources are covering this

STAT+: Pharmalittle: We’re reading about drug launch prices, an AstraZeneca AI deal, and more

More from Health

STAT+: A bipartisan group of lawmakers urges the FDA to close a peptide loophole

STAT+: Roche continues to look to China for new drugs

Vanessa Kerry is the new WHO envoy for health resilience. What's on her to-do list?

Why I wish you didn’t want to see Nathan Fielder’s Elizabeth Holmes documentary

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Pharmalittle: We&#8217;re reading about drug launch prices, an AstraZeneca AI deal, and more

More from Health

STAT+: A bipartisan group of lawmakers urges the FDA to close a peptide loophole

STAT+: Roche continues to look to China for new drugs

Vanessa Kerry is the new WHO envoy for health resilience. What's on her to-do list?

Why I wish you didn’t want to see Nathan Fielder’s Elizabeth Holmes documentary

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about drug launch prices, an AstraZeneca AI deal, and more